MTOR and glioblastoma: There are also reports on the role of CCL5 in activating the mammalian target of rapamycin (mTOR) pathway, which has been shown to be critical for the maintenance of GSCs and the survival of mesenchymal glioblastoma tumour cells [85,95,96].